loading page

Metabolic Diversity of Tumor-infiltrating T Cells as Target for Anti-immune Therapeutics
  • +1
  • Peipei Li,
  • Fangchao Li,
  • Yanfei Zhang,
  • Jingjing Li
Peipei Li
BGI genomics
Author Profile
Fangchao Li
Author Profile
Yanfei Zhang
Author Profile
Jingjing Li
Weifang Medical University

Corresponding Author:[email protected]

Author Profile


Tumor-infiltrating T cells are promising drug targets to modulate the tumor microenvironment. However, tumor-infiltrating T lymphocytes, as central targets of cancer immunotherapy, show considerable heterogeneity and dynamics across tumor microenvironments and cancer types that may fundamentally influence cancer growth, metastasis, relapse, and response to clinical drugs. The T cell heterogeneity not only refers to the composition of subpopulations but also divergent metabolic states of T cells. Comparing to the diversity of tumor-infiltrating T cell compositions that have been well recognized, the metabolic diversity of T cells deserves more attention for precision immunotherapy. Single-cell sequencing technology enables panoramic stitching of the tumor bulk, partly by showing the metabolic related gene expression profiles of tumor-infiltrating T cells at a single-cell resolution. Therefore, we here discuss T cell metabolism reprogramming triggered by tumor microenvironment as well as the potential application of metabolic targeting drugs. The tumor-infiltrating T cells metabolic pathway addictions among different cancer types are also addressed in this brief review.